Integral Ad Science (NASDAQ:IAS) Price Target Cut to $18.00 by Analysts at Oppenheimer

Integral Ad Science (NASDAQ:IAS) had its price objective reduced by Oppenheimer from $20.00 to $18.00 in a report issued on Wednesday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

A number of other analysts have also recently issued reports on IAS. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research note on Monday, August 5th. Barclays boosted their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Monday, August 5th. Raymond James upped their price objective on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Friday, August 2nd. Finally, Morgan Stanley upped their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 23rd. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $15.70.

Integral Ad Science Trading Down 6.1 %

NASDAQ IAS opened at $10.11 on Wednesday. The firm’s 50 day moving average price is $11.09 and its two-hundred day moving average price is $10.47. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.76 and a current ratio of 3.71. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53. The stock has a market cap of $1.64 billion, a price-to-earnings ratio of 50.55, a PEG ratio of 1.46 and a beta of 1.52.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $133.50 million during the quarter, compared to analyst estimates of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.09) earnings per share. Equities analysts anticipate that Integral Ad Science will post 0.25 EPS for the current year.

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the transaction, the chief executive officer now directly owns 239,709 shares in the company, valued at approximately $2,423,457.99. This represents a 4.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Tania Secor sold 6,643 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $11.24, for a total value of $74,667.32. Following the completion of the sale, the chief financial officer now owns 251,366 shares of the company’s stock, valued at approximately $2,825,353.84. This represents a 2.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,006 shares of company stock worth $240,296. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

A number of institutional investors have recently bought and sold shares of the stock. Swiss National Bank increased its stake in shares of Integral Ad Science by 30.2% during the first quarter. Swiss National Bank now owns 140,600 shares of the company’s stock valued at $1,402,000 after buying an additional 32,600 shares during the period. ProShare Advisors LLC purchased a new position in Integral Ad Science in the first quarter valued at about $121,000. Jupiter Asset Management Ltd. purchased a new position in Integral Ad Science in the first quarter valued at about $3,257,000. Vanguard Group Inc. grew its stake in Integral Ad Science by 7.0% in the first quarter. Vanguard Group Inc. now owns 8,673,229 shares of the company’s stock valued at $86,472,000 after purchasing an additional 566,982 shares during the last quarter. Finally, Ameritas Investment Partners Inc. grew its stake in Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares during the last quarter. 95.78% of the stock is currently owned by institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.